{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T23:27:40Z","timestamp":1784417260300,"version":"3.55.0"},"reference-count":71,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2004,10,12]],"date-time":"2004-10-12T00:00:00Z","timestamp":1097539200000},"content-version":"vor","delay-in-days":3329,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Movement Disorders"],"published-print":{"date-parts":[[1995,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Oxidant stress secondary to dopamine metabolism has been proposed as a pathogenic factor in the development of Parkinson's disease. Biochemical abnormalities extending beyond the central nervous system have been identified in patients with this condition. Previous investigators have found abnormally elevated concentrations of the lipid peroxidation product, malondialdehyde, in the plasma and serum of patients with Parkinson's disease. We attempted to replicate these findings but controlled for other factors that could influence malondialdehyde levels. We detected no significant elevations in mean serum malondialdehyde concentrations in either levodopatreated or untreated patients with Parkinson's disease, compared to normal controls; similarly, no elevation was found in a group of patients with dementia of Alzheimer's type. On the other hand, a group of subjects with diabetes mellitus but no neurodegenerative disease had significantly elevated mean serum malondialdehyde levels, consistent with previous studies of diabetic patients. Autoxidation is one of the two major routes by which dopamine and dopa metabolism may generate oxygen free radicals. We analyzed the autoxidation product of dopa, 5\u2010<jats:italic>S<\/jats:italic>\u2010cysteinyl\u2010dopa, in the plasma of these same groups of patients with neurodegenerative disease and normal controls; no significant differences were identified. Serum concentrations of two other antioxidant substances, \u03b1\u2010tocopherol and uric acid, were also statistically similar in these groups. In conclusion, analysis of several blood products relevant to oxidant stress, including malondialdehyde, 5\u2010<jats:italic>S<\/jats:italic>\u2010cysteinyl\u2010dopa, \u03b1\u2010tocophero, and uric acid, failed to distinguish patients with Parkinson's disease or dementia of Alzheimer's type from controls.<\/jats:p>","DOI":"10.1002\/mds.870100507","type":"journal-article","created":{"date-parts":[[2004,12,31]],"date-time":"2004-12-31T09:43:25Z","timestamp":1104486205000},"page":"566-573","source":"Crossref","is-referenced-by-count":75,"title":["No evidence for systemic oxidant stress in Parkinson's or Alzheimer's disease"],"prefix":"10.1002","volume":"10","author":[{"given":"J. Eric","family":"Ahlskog","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan J.","family":"Uitti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip A.","family":"Low","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gertrude M.","family":"Tyce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim K.","family":"Nickander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald C.","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emre","family":"Kokmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2004,10,12]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0095-4543(21)00254-2","article-title":"The skin in Parkinson's disease","volume":"4","author":"Flint A","year":"1977","journal-title":"Prim Care"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410260606"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02257619"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410320612"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(89)90291-2"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510X(91)90311-T"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410300304"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.43.11.2258"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(89)92366-0"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1990.tb05809.x"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410300409"},{"issue":"3","key":"e_1_2_1_13_2","first-page":"32","article-title":"Oxidation reactions in Parkinson's disease","volume":"40","author":"Olanow CW","year":"1990","journal-title":"Neurology"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410320616"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1989.tb09133.x"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(88)90467-3"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00227575"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2944(79)90061-9"},{"key":"e_1_2_1_19_2","first-page":"173","article-title":"Thiobarbituric acid test as a measure of lipid peroxidation in Arab patients with NIDDM","volume":"15","author":"Abdella N","year":"1990","journal-title":"Diabetes Res Clin Exp"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(90)90985-A"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0753-3322(91)90107-5"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.65.5.245"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510X(91)90118-Q"},{"key":"e_1_2_1_24_2","first-page":"81","article-title":"Free radical production in peripheral vascular disease. A risk for critical ischaemia?","volume":"10","author":"Ciuffetti G","year":"1991","journal-title":"Int Angiol"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1536\/ihj.33.145"},{"key":"e_1_2_1_26_2","doi-asserted-by":"crossref","first-page":"909","DOI":"10.2337\/diab.41.8.909","article-title":"Free radical activity and hemostatic factors in NIDDM patients with and without microalbuminuria","volume":"41","author":"Collier A","year":"1992","journal-title":"Diabetes"},{"key":"e_1_2_1_27_2","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1182\/blood.V79.5.1334.1334","article-title":"Increased susceptibility of the sickle cell membrane Ca2+ Mg2+\u2010ATPase to t\u2010butylhydroperoxide: protective effects of ascorbate and desferal","volume":"79","author":"Moore RB","year":"1992","journal-title":"Blood"},{"key":"e_1_2_1_28_2","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1177\/089686089201200213","article-title":"Lipid peroxidation and antioxidants in continuous ambulatory dialysis patients","volume":"12","author":"Taylor JE","year":"1992","journal-title":"Perit Dial Int"},{"key":"e_1_2_1_29_2","first-page":"429","article-title":"Serum malondialdehyde and mitochondrial aspartate aminotransferase activity as markers of chronic alcohol intake and alcoholic liver disease","volume":"25","author":"Baldi E","year":"1993","journal-title":"Ital J Gastroenterol"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410060409"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.34.8.1114"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1986.00520070020010"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.37.5.754"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510X(80)90175-6"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198504183121618"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.83.8.2758"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410220208"},{"key":"e_1_2_1_38_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.40.8.1302"},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)91705-Q"},{"key":"e_1_2_1_40_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.43.8.1467"},{"key":"e_1_2_1_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(94)91151-7"},{"key":"e_1_2_1_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(86)90242-X"},{"key":"e_1_2_1_43_2","first-page":"12","article-title":"Role of catechol autooxidation in the degeneration of dopamine neurons","volume":"129","author":"Fornstedt B","year":"1990","journal-title":"Acta Neurol Scand Suppl"},{"key":"e_1_2_1_44_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.1991.tb05014.x"},{"issue":"2","key":"e_1_2_1_45_2","first-page":"50","article-title":"Catechol metabolites in the cerebrospinal fluid as possible markers in the early diagnosis of Parkinson's disease","volume":"41","author":"Carlsson A","year":"1991","journal-title":"Neurology"},{"key":"e_1_2_1_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/0378-4347(87)80232-3"},{"key":"e_1_2_1_47_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1990.tb01910.x"},{"key":"e_1_2_1_48_2","first-page":"321","article-title":"Dopa in plasma increases during acute exercise and after exercise training","volume":"114","author":"Devalon ML","year":"1989","journal-title":"J Lab Clin Med"},{"key":"e_1_2_1_49_2","doi-asserted-by":"publisher","DOI":"10.1248\/cpb.29.158"},{"key":"e_1_2_1_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(90)90319-G"},{"key":"e_1_2_1_51_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1991.tb03204.x"},{"key":"e_1_2_1_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(92)80074-Q"},{"key":"e_1_2_1_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(92)90033-4"},{"key":"e_1_2_1_54_2","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/S0026-895X(25)13536-0","article-title":"Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6\u2010hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro","volume":"14","author":"Graham DG","year":"1978","journal-title":"Mol Pharmacol"},{"key":"e_1_2_1_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0026-895X(25)13535-9"},{"key":"e_1_2_1_56_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02263482"},{"key":"e_1_2_1_57_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1991.tb08166.x"},{"key":"e_1_2_1_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/0009-8981(78)90276-0"},{"key":"e_1_2_1_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-4347(00)84702-7"},{"key":"e_1_2_1_60_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1990.tb04183.x"},{"key":"e_1_2_1_61_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1988.00520360068014"},{"key":"e_1_2_1_62_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870050116"},{"key":"e_1_2_1_63_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410320722"},{"key":"e_1_2_1_64_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199301213280305"},{"key":"e_1_2_1_65_2","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.68.802.634"},{"key":"e_1_2_1_66_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.42.5.1064"},{"key":"e_1_2_1_67_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.43.3_Part_1.634-a"},{"key":"e_1_2_1_68_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410320420"},{"key":"e_1_2_1_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(86)91819-2"},{"key":"e_1_2_1_70_2","doi-asserted-by":"publisher","DOI":"10.1159\/000213037"},{"key":"e_1_2_1_71_2","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/21.2.91"},{"key":"e_1_2_1_72_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1990.tb08858.x"}],"container-title":["Movement Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fmds.870100507","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/movementdisorders.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/mds.870100507","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T12:18:43Z","timestamp":1760962723000},"score":1,"resource":{"primary":{"URL":"https:\/\/movementdisorders.onlinelibrary.wiley.com\/doi\/10.1002\/mds.870100507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,9]]},"references-count":71,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1995,9]]}},"alternative-id":["10.1002\/mds.870100507"],"URL":"https:\/\/doi.org\/10.1002\/mds.870100507","archive":["Portico"],"relation":{},"ISSN":["0885-3185","1531-8257"],"issn-type":[{"value":"0885-3185","type":"print"},{"value":"1531-8257","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,9]]}}}